Bonomore Tablet 20mg (Bazedoxifene Acetate)

Adult dose

1 tablet (as Bazedoxifene 20mg) once daily, irrespective of meals.

This medication may increase the risk of venous thromboembolism; therefore, it is not recommended for women with a history of or risk factors for deep vein thrombosis, pulmonary embolism, or retinal vein thrombosis. This medication should only be used in postmenopausal women; premenopausal women or those who may become pregnant should not take it. If unexpected uterine bleeding occurs while taking this medication, a healthcare professional should be consulted immediately. Its safety has not been confirmed when used in conjunction with breast cancer patients or medications related to breast cancer, so usage should be avoided. Patients with hypersensitivity to this medication or its components, a history of venous thromboembolism, pregnant or nursing women, those with unexplained uterine bleeding, and those with symptoms of endometrial cancer should not take this medication. Patients with genetic issues such as lactose intolerance should also avoid this medication. Patients with hypertriglyceridemia, severe renal impairment, or liver dysfunction should use this medication with caution, and the use is specifically not recommended for those with liver dysfunction. Drowsiness and visual disturbances may occur when taking this medication, so caution is needed when driving or operating machinery. The potential for drug interactions with this medication is low; however, certain drugs may alter the metabolism of this medication, so a discussion with a physician is advised. Women who are pregnant or may become pregnant should not take this medication, and nursing mothers should also not use it. It is not for use in children, and elderly patients can use it without special dosage adjustment but should consider changes in liver function. There is no specific antidote for overdose; treatment should be based on symptoms. This medication should be stored away from children and kept in its original container. Various adverse reactions such as facial flushing, leg cramps, thrombosis, gastrointestinal disturbances may occur while taking this medication, so consultation with a physician is needed if any abnormal symptoms occur.

Serious side effects

• Urticaria
• retinal vein thrombosis
• deep vein thrombosis
• pulmonary embolism
• superficial venous thrombosis
• pulmonary embolism
• chest discomfort
• generalized edema
• swelling
• facial swelling

Mild side effects

Vasodilation (facial flushing), leg cramps, drowsiness, dry mouth, rash, itching, muscle cramps, elevated triglycerides, increased alanine aminotransferase (ALT), increased aspartate aminotransferase (AST), visual impairment, blurred vision, photophobia, visual field defects, vision disturbances, dry eyes, eyelid swelling, eyelid spasms, eye pain, symptoms of eye swelling, vomiting, gastritis, belching, dermatitis, localized skin reactions, sweating

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. Additionally, it is important to store it at a cool temperature below 25 degrees Celsius to maintain its effectiveness.

Appearance

White oblong film-coated tablets

Package unit

30 tablets (10 tablets/PTP x 3)